New grant: Ox4TB Philip Fowler, 17th March 202517th March 2025 Very pleased to announce that I am a co-investigator on the recently announced Oxford4TB project that has been funded by the Ineos Oxford Institute for antimicrobial research (IOI). The project will received £5 million over three years and the main aim is to develop new therapies for multi-drug resistant tuberculosis. We will be guiding the selection of targets and leads using our large dataset of >50k clinical tuberculosis samples. Each sample has phenotypic drug susceptibility testing and whole genome data so we will be able to e.g. check there are no mutations in circulation that could lead to resistance of any new compound. I will be advertising a post to work on this project in a few months time. Share this:TwitterBlueskyEmailLinkedInMastodon Related antimicrobial resistance clinical microbiology tuberculosis
New publication: determining novel mechanisms of bedaquiline resistance 30th March 20235th April 2023 A new paper with Lindsay Sonnenkalb as first-author has just been published in The Lancet… Share this:TwitterBlueskyEmailLinkedInMastodon Read More
GPAS stopover on the ORACLE road trip 1st February 20221st February 2022 You can listen to Philip Fowler talk about the Global Pathogen Analysis System (GPAS) as… Share this:TwitterBlueskyEmailLinkedInMastodon Read More
antimicrobial resistance New preprint: Predicting antibiotic resistance in complex protein targets 4th January 20224th January 2022 In this preprint, which Alice has been working on for several years, we show how… Share this:TwitterBlueskyEmailLinkedInMastodon Read More